Indore: A five-month-old boy has been diagnosed with Multi Drug Resistant Tuberculosis (MDR-TB) which surprised doctors of Indore as it is the first case of TB in such a young one. The patient was diagnosed with MDR-TB and brain TB on Friday. According to nodal officer of tuberculosis control Dr Vijay Chhajlani this is the first case in Madhya Pradesh that a five-month-old boy has been detected with MDR-TB and brain TB.
The patient is a resident of Navlakha area and his father is a labourer. Around 12 days ago he was taken to a private hospital by family members with complaint of cough and cold. As the expenses of private hospital were high, the family members admitted the child to Chacha Nehru Hospital.
The child suffered fits following which the doctors conducted examinations which led to detection of MDR-TB and brain TB. Dr Chhajlani said, “The patient does not have a family history of tuberculosis. We have sent the samples of family members for examination. The exact reason of exposure of the child to TB bacteria is still not clear.” “We will also inspect the hospital were the child was born to know about any exposure during the delivery”, he added. The child was on ventilator since past two days. The doctors are now planning to remove him from the ventilator.
First case in Madhya Pradesh
Dr Vijay Chhajlani said, “Earlier TB was detected in children of 5 to 6 years of age. This is the first incident in Madhya Pradesh where a five-month-old child is detected suffering from MDR-TB and brain TB.
11,000 TB cases reported in Indore district in 2018
As many as new 11,000 TB cases were reported in 2018 in Indore district as per the data provided by District Health Committee-TB. The data was released in annual review meeting of Revised National Tuberculosis Control Programme (RNTPC).
Dr Chhajlani said that the government has installed five Cibinot machines in Indore district to control the increasing cases of multi drug resistant (MDR) TB. In 2018, Cibnot tests were conducted on 10324 patients of which, 282 were found to be resistant to certain drugs following which they were treated with DOT plus therapy.